Back to the Top
The following message was posted to: PharmPK
I need your comments regarding to following issue:
Miglitol is an alfa glucosidase inhibitor which is used for glycaemic
control. Due to the pharmacokinetic properties of miglitol, it is not
needed to perform bioequivalance study.
Do you have any experience for this drug?
Do you have any documentation for the bioequivalance study of generic
Can I classify it as BCS Class I?
Pharm. Hatice Atkaya
Ali Raif Pharmaceutical Company
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Miglitol BE" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (email@example.com)